Xolair 300 MG/2 ML syringe 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FKJG6
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,899
Award facts
- Contract value 100% obligated
- $1,898.74 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $1,898.74 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Xolair 300 mg/2 ml syringes. The contract, issued on November 24, 2025, with an ultimate completion date of December 16, 2025, contains no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. This delivery order was issued under DMS Pharmaceutical Group's broader Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, designated as contract SPE2DR.
The PPV-G GEN V represents a $30.3 billion Defense Logistics Agency acquisition strategy designed to establish multiple regional prime vendor contractors capable of supplying comprehensive pharmaceutical products, including branded and generic prescription medications, biologics, and medical consumables to support Department of Defense healthcare operations worldwide. DMS Pharmaceutical Group's single-award IDC under this program, valued at $499,999,999 with a completion date of December 31, 2036, positions the company as a critical supplier within the federal military medical supply chain. The contractor's extensive product portfolio and demonstrated performance across numerous delivery orders underscore its capability to fulfill the specialized pharmaceutical requirements of DoD healthcare facilities globally.
Quick answers
Who was awarded contract SPE2DR26FKJG6?
SPE2DR26FKJG6 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 24, 2025.
How much is contract SPE2DR26FKJG6 worth?
The government has obligated $1,899 on SPE2DR26FKJG6.
Is contract SPE2DR26FKJG6 an order under another contract?
Yes. SPE2DR26FKJG6 is a delivery order under SPE2DR25D9105, an indefinite delivery contract.
Was contract SPE2DR26FKJG6 competed?
The extent of competition for SPE2DR26FKJG6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award